Cibus, Inc. (CBUS) Insider Trading Activity

NASDAQ$1.47
Market Cap
$71.13M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
479 of 871
Rank in Industry
279 of 500

CBUS Insider Trading Activity

CBUS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$308,235
62
100

Related Transactions

Broos CarloInterim CFO
0
$0
1
$24,629
$-24,629
Gocal Gregory Francis WilliamChief Scientific Officer & EVP
0
$0
3
$60,023
$-60,023
Prante Gerharddirector
0
$0
58
$223,583
$-223,583

About Cibus, Inc.

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Insider Activity of Cibus, Inc.

Over the last 12 months, insiders at Cibus, Inc. have bought $0 and sold $308,235 worth of Cibus, Inc. stock.

On average, over the past 5 years, insiders at Cibus, Inc. have bought $0 and sold $308,235 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Cibus, Inc.

2025-02-25SalePrante Gerharddirector
1,150
0.0031%
$1.92
$2,208
+3.57%
2025-02-24SalePrante Gerharddirector
1,150
0.0034%
$2.07
$2,381
+5.21%
2025-02-21SalePrante Gerharddirector
1,150
0.0035%
$2.20
$2,530
-3.37%
2025-02-20SalePrante Gerharddirector
1,150
0.0034%
$2.35
$2,703
-6.48%
2025-02-19SalePrante Gerharddirector
1,150
0.0034%
$2.58
$2,967
-12.88%
2025-02-18SalePrante Gerharddirector
2,300
0.0068%
$2.52
$5,796
-22.03%
2025-02-14SalePrante Gerharddirector
1,150
0.0034%
$2.60
$2,990
-19.37%
2025-02-13SalePrante Gerharddirector
1,150
0.0034%
$2.53
$2,910
-21.04%
2025-02-12SalePrante Gerharddirector
1,150
0.0033%
$2.45
$2,818
-18.97%
2025-02-11SalePrante Gerharddirector
1,150
0.0034%
$2.48
$2,852
-18.65%
2025-02-10SalePrante Gerharddirector
1,150
0.0034%
$2.52
$2,898
-18.33%
2025-02-07SalePrante Gerharddirector
1,150
0.0034%
$2.50
$2,875
-17.88%
2025-02-06SalePrante Gerharddirector
1,150
0.0034%
$2.55
$2,933
-17.76%
2025-02-05SalePrante Gerharddirector
1,150
0.0034%
$2.52
$2,898
-17.61%
2025-02-04SalePrante Gerharddirector
1,150
0.0034%
$2.45
$2,818
-17.46%
2025-02-03SalePrante Gerharddirector
1,150
0.0033%
$2.41
$2,772
-15.69%
2025-01-31SalePrante Gerharddirector
1,150
0.0039%
$2.55
$2,933
-16.27%
2025-01-30SalePrante Gerharddirector
1,150
0.0034%
$2.46
$2,829
-18.14%
2025-01-29SalePrante Gerharddirector
1,150
0.0037%
$2.42
$2,783
-13.99%
2025-01-28SalePrante Gerharddirector
1,150
0.0037%
$2.44
$2,806
-14.14%
Total: 62
*Gray background shows transactions not older than one year

CBUS Institutional Investors: Active Positions

Increased Positions36+53.73%3M+32.53%
Decreased Positions24-35.82%419,510-4.44%
New Positions11New2MNew
Sold Out Positions9Sold Out211,025Sold Out
Total Postitions79+17.91%12M+28.1%

CBUS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fmr Llc$8,929.0012.03%3.97M+55,058+1.41%2024-12-31
Vantage Consulting Group Inc$2,574.003.47%1.14M00%2024-12-31
Blackrock, Inc.$2,529.003.41%1.12M-12,668-1.11%2025-03-31
Vanguard Group Inc$1,914.002.58%850,490+11,538+1.38%2024-12-31
Geode Capital Management, Llc$883.001.19%392,387+27,464+7.53%2024-12-31
State Street Corp$732.000.99%325,538+18,276+5.95%2024-12-31
Granby Capital Management, Llc$450.000.61%200,000+150,000+300%2024-12-31
Northern Trust Corp$342.000.46%152,122+12,832+9.21%2024-12-31
Millennium Management Llc$287.000.39%127,440-15,409-10.79%2024-12-31
Renaissance Technologies Llc$286.000.39%127,100+114,800+933.33%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.